Therapeutic drug monitoring (TDM) of antifungal agents: Guidelines from the british society for medical mycology

673Citations
Citations of this article
513Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The burden of human disease related to medically important fungal pathogens is substantial. An improved understanding of antifungal pharmacology and antifungal pharmacokinetics-pharmacodynamics has resulted in therapeutic drug monitoring (TDM) becoming a valuable adjunct to the routine administration of some antifungal agents. TDM may increase the probability of a successful outcome, prevent drug-related toxicity and potentially prevent the emergence of antifungal drug resistance. Much of the evidence that supports TDM is circumstantial. This document reviews the available literature and provides a series of recommendations for TDM of antifungal agents.© The Author 2013. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.All rights reserved.

Cite

CITATION STYLE

APA

Ashbee, H. R., Barnes, R. A., Johnson, E. M., Richardson, M. D., Gorton, R., & Hope, W. W. (2014). Therapeutic drug monitoring (TDM) of antifungal agents: Guidelines from the british society for medical mycology. Journal of Antimicrobial Chemotherapy, 69(5), 1162–1176. https://doi.org/10.1093/jac/dkt508

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free